视网膜母细胞瘤

Villegas VM, Hess DJ, Wildner A, et al. Retinoblastoma. Curr Opin Ophthalmol. 2013;24:581-588.

• 摘要

Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41-53.

• 摘要

Mastrangelo D, De Francesco S, Di Leonardo A, et al. Does the evidence matter in medicine? The retinoblastoma paradigm. Int J Cancer. 2007;121:2501-2505.

• 全文
• 摘要

Houston SK, Pina Y, Clarke J, et al. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors. Invest Ophthalmol Vis Sci. 2011;52:5359-5368.

• 全文
• 摘要

Ajioka I, Dyer MA. A new model of tumor susceptibility following tumor suppressor gene activation. Cell Cycle. 2008;7:735-740.

• 摘要

Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129:732-737.

• 摘要

1.  Villegas VM, Hess DJ, Wildner A, et al. Retinoblastoma. Curr Opin Ophthalmol. 2013;24:581-588.

• 摘要

2.  Schefler AC, Abramson DH. Retinoblastoma: what is new in 2007-2008. Curr Opin Ophthalmol. 2008;19:526-534.

• 摘要

3.  Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41-53.

• 摘要

4.  Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24:828-848.

• 摘要

5.  Ballarati L, Elena Rossi E, Bonati MT, et al. 13q deletion and central nervous system anomalies: further insights from karyotype - phenotype analyses of 14 patients. J Med Genet. 2007;44:e60.

• 摘要

6.  Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol. 1990;108:128-132.

• 摘要

7.  Childhood Eye Cancer Trust. Information about retinoblastoma for health professionals. https://chect.org.uk/ (last accessed 11 August 2017).

• 全文

8.  Augsburger JJ, Oehlschlager U, Manzitti JE. Multinational clinical and pathologic registry of retinoblastoma. Retinoblastoma International Collaborative Study report 2. Graefes Arch Clin Exp Ophthalmol. 1995;233:469-475.

• 摘要

9.  Mastrangelo D, De Francesco S, Di Leonardo A, et al. Does the evidence matter in medicine? The retinoblastoma paradigm. Int J Cancer. 2007;121:2501-2505.

• 全文
• 摘要

10.  Dimaras H, Khetan V, Halliday W, et al. Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008;17:1363-1372.

• 摘要

11.  Houston SK, Pina Y, Clarke J, et al. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors. Invest Ophthalmol Vis Sci. 2011;52:5359-5368.

• 全文
• 摘要

12.  Leiderman YI, Kiss S, Mukai S. Molecular genetics of RB1 - the retinoblastoma gene. Semin Ophthalmol. 2007;22:247-254.

• 摘要

13.  Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000;6:4010-4016.

• 全文
• 摘要

14.  Dryja TP, Mukai S, Petersen R, et al. Parental origin of mutations of the retinoblastoma gene. Nature. 1989;339:556-558.

• 摘要

15.  DerKinderen DJ, Koten JW, Tan KE, et al. Parental age in sporadic hereditary retinoblastoma. Am J Ophthalmol. 1990;110:605-609.

• 摘要

16.  Matsunaga E, Minoda K, Sasaki MS. Parental age and seasonal variation in the births of children with sporadic retinoblastoma: a mutation-epidemiologic study. Hum Genet. 1990;84:155-158.

• 摘要

17.  Ajioka I, Dyer MA. A new model of tumor susceptibility following tumor suppressor gene activation. Cell Cycle. 2008;7:735-740.

• 摘要

18.  Xu K, Rosenwaks Z, Beaverson K, et al. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol. 2004;137:18-23.

• 摘要

19.  Truong B, Green AL, Friedrich P, et al. Ethnic, racial, and socioeconomic disparities in retinoblastoma. JAMA Pediatr. 2015;169:1096-1104.

• 摘要

20.  Vigoda MM, Latiff A, Murray TG, et al. Can children undergoing ophthalmologic examinations under anesthesia be safely anesthetized without using an IV line? Clin Ophthalmol. 2011;5:503-508.

• 全文
• 摘要

21.  Houston SK, Berrocal AM, Murray TG. The future of diagnostic imaging in retinoblastoma. J AAPOS. 2011;15:125-126.

• 摘要

22.  Mohney BG, Robertson DM. Ancillary testing for metastasis in patients with newly diagnosed retinoblastoma. Am J Ophthalmol. 1994;118:707-711.

• 摘要

23.  Silva RA, Dubovy SR, Fernandes CE, et al. Retinoblastoma with Coats' response. Ophthalmic Surg Lasers Imaging. 2011;42:e139-e143.

• 摘要

24.  Schefler AC, Cicciarelli N, Feuer W, et al. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology. 2007;114:162-169.

• 摘要

25.  Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129:732-737.

• 摘要

26.  Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117:1623-1629.

• 摘要

27.  Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol. 2011;5:171-176.

• 全文
• 摘要

28.  Houston SK, Wykoff CC, Berrocal AM, et al. Lasers for the treatment of intraocular tumors. Lasers Med Sci. 2013;28:1025-1034.

• 摘要

29.  Scott IU, Murray TG, Feuer WJ, et al. External beam radiotherapy in retinoblastoma: tumor control and comparison of 2 techniques. Arch Ophthalmol. 1999;117:766-770.

• 摘要

30.  Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol. 2004;122:1316-1323.

• 摘要

31.  Leng T, Cebulla CM, Schefler AC, et al. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma. Retina. 2010;30(suppl 4):S66-S68.

• 摘要

32.  Mulvihill A, Budning A, Jay V, et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol. 2003;12:1120-1124.

• 摘要

33.  Schmack I, Hubbard GB, Kang SJ, et al. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for retinoblastoma. Am J Ophthalmol. 2006;142:310-315.

• 摘要

34.  Uusitalo MS, Van Quill KR, Scott IU, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol. 2001;119:41-48.

• 摘要

35.  Chantada GL, Dunkel IJ, de Dávila MT, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88:1069-1073.

• 全文
• 摘要

36.  Zelter M, Damel A, Gonzalez G, et al. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer. 1991;68:1685-1690.

• 摘要

37.  Kiratli H, Bilgiç S, Ozerdem U. Management of massive orbital involvement of intraocular retinoblastoma. Ophthalmology. 1998;105:322-326.

• 摘要

38.  Goble RR, McKenzie J, Kingston JE, et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol. 1990;74:97-98.

• 全文
• 摘要

39.  Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma: the experience of a single institution with 33 patients. Cancer. 1994;74:722-732.

• 摘要

40.  Sandri A, Besenzon L, Acquaviva A, et al. "Eight drugs in one day" chemotherapy in a nonfamilial bilateral retinoblastoma with recurrent cerebrospinal fluid metastases. Pediatr Hematol Oncol. 1998;15:557-561.

• 摘要

41.  Doz F, Neuenschwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol. 1995;13:902-909.

• 摘要

42.  Namouni F, Doz F, Tanguy ML, et al. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer. 1997;33:2368-2375.

• 摘要

43.  White L. Chemotherapy for retinoblastoma. Med Pediatr Oncol. 1995;24:341-342.

• 摘要

44.  Schouten-Van Meeteren AY, Moll AC, Imhof SM, et al. Overview: chemotherapy for retinoblastoma: an expanding area of clinical research. Med Pediatr Oncol. 2002;38:428-438.

• 摘要

45.  Matsubara H, Makimoto A, Higa T, et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant. 2005;35:763-766.

• 摘要

46.  Kremens B, Wieland R, Reinhard H, et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant. 2003;31:281-284.

• 摘要

47.  Hertzberg H, Kremens B, Velten I, et al. Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001;27:653-655.

• 摘要

48.  Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer. 2000;89:2117-2121.

• 摘要

49.  Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116-2121.

• 摘要

50.  Merchant TE, Gould CJ, Wilson MW, et al. Episcleral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer. 2004;43:134-139.

• 摘要

51.  Munier FL, Gaillard MC, Balmer A, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96:1078-1083.

• 摘要

52.  Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol. 2012;130:1268-1271.

• 全文
• 摘要

53.  Smith SJ, Smith BD. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2013;97:1231-1236.

• 摘要

54.  Shields CL, Douglass AM, Beggache M, et al. Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: outcomes after 192 consecutive injections - the 2015 Howard Naquin lecture. Retina. 2016;36:1184-1190.

• 摘要

55.  Rivera GK, Pui CH, Santana VM, et al. Epipodophyllotoxins in the treatment of childhood cancer. Cancer Chemother Pharmacol. 1994;34 Suppl:S89-S95.

• 摘要